WFH/wfh.org
Nov 14, 2026, 14:14
Expanding Global Access to Gene Therapy – WFH
World Federation of Hemophilia shared a post on LinkedIn:
“We wrapped up our 19th New Technology and Gene Therapy (NTGT) Workshop in Montréal today with a question.
How can advances in treatment reach more people with bleeding disorders worldwide?
On Day 2, we explored ways to make gene therapy more durable, emerging treatments for other rare bleeding disorders, and what it takes to expand access.
Thank you to everyone who joined us to mark 30 years of scientific innovation and exchange.
See more in the gallery.
Stay updated with Hemostasis Today.
-
Nov 14, 2026, 15:07Vaidehi Prasanth: Patient Blood Management in Hematological Patients A New Book Chapter
-
Nov 14, 2026, 15:00Ram Mohan Jaiswal: International Collaboration in Transfusion Medicine Through the Trans Med Africa Consortium
-
Nov 14, 2026, 14:48Jamie Sin Ying Ho: Stopping Anticoagulation After AF Ablation and Rhythm Control
-
Nov 14, 2026, 14:29Satya Prakash: Cell-Free Hemoglobin-Based Oxygen Carriers and Their Clinical Development
-
Nov 14, 2026, 14:24Adela Castro: Distinguishing Antiphospholipid Antibodies From APS in Pregnancy
-
Nov 14, 2026, 14:20Uzima Chirwa: Rethinking Comprehensive Care for Bleeding Disorders in Africa
-
Nov 14, 2026, 14:19Samuele Ferrari: Launching a New Era in Hematopoietic Genome Editing Research
-
Nov 14, 2026, 14:17Stefan Hofer: International Training in Postpartum Hemorrhage Management
-
Nov 14, 2026, 14:11Cedric Hermans: Advancing Haemophilia Care Through Innovation and Global Access